name:-0.025155067443848
name:-0.025557041168213
name:-0.0055789947509766
SIMONS; Michael Patent Filings

SIMONS; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for SIMONS; Michael.The latest application filed is for "methods and compositions for treating pulmonary arterial hypternsion".

Company Profile
7.25.24
  • SIMONS; Michael - New Haven CT
  • Simons; Michael - Hamden CT
  • SIMONS; Michael - Hillsborough CA
  • Simons; Michael - Hanover NJ
  • Simons; Michael - Chestnut Hill MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Methods And Compositions For Treating Pulmonary Arterial Hypternsion
App 20220233573 - SIMONS; Michael
2022-07-28
Methods and compositions for treating atherosclerosis
Grant 11,326,167 - Simons , et al. May 10, 2
2022-05-10
Drink Lid Arrangements And Methods
App 20220125227 - BREWSTER; Peter Hollister ;   et al.
2022-04-28
Methods and Compositions to Alleviate Vascular Permeability
App 20210113654 - Simons; Michael ;   et al.
2021-04-22
Drink Lid Arrangements And Methods
App 20200229624 - BREWSTER; Peter Hollister ;   et al.
2020-07-23
Compositions and methods for controlling vasculature
Grant 10,450,570 - Simons , et al. Oc
2019-10-22
Methods And Compositions For Treating Atherosclerosis
App 20190100760 - SIMONS; Michael ;   et al.
2019-04-04
Drink lid arrangements and methods
Grant 10,226,141 - Brewster , et al.
2019-03-12
Compositions And Methods For Controlling Vasculature
App 20180163210 - SIMONS; Michael ;   et al.
2018-06-14
Electronic lid device for a beverage
Grant D804,306 - Simons , et al. December 5, 2
2017-12-05
Compositions and methods for treating and preventing neointimal stenosis
Grant 9,782,522 - Breuer , et al. October 10, 2
2017-10-10
Electronic lid device for a beverage
Grant D792,220 - Simons , et al. July 18, 2
2017-07-18
Compositions and Methods for Treating and Preventing Neointimal Stenosis
App 20160310645 - Breuer; Christopher ;   et al.
2016-10-27
Compositions and methods for treating and preventing neointimal stenosis
Grant 9,446,175 - Breuer , et al. September 20, 2
2016-09-20
Drink Lid Arrangements And Methods
App 20150053702 - BREWSTER; Peter Hollister ;   et al.
2015-02-26
Compositions and Methods for Treating and Preventing Neointimal Stenosis
App 20140348889 - Breuer; Christopher ;   et al.
2014-11-27
Sanitizing lid and dispatch service thereof
Grant 8,876,166 - Brewster , et al. November 4, 2
2014-11-04
Stimulation of Arterial Collateral Growth and Lymphogenesis
App 20140120106 - Simons; Michael ;   et al.
2014-05-01
Sanitizing Lid And Dispatch Service Thereof
App 20120104741 - Brewster; Peter Hollister ;   et al.
2012-05-03
Mutant proline-and-arginine rich peptides and methods for using the same
Grant 8,030,446 - Veeraraghavan , et al. October 4, 2
2011-10-04
Method for increasing cardiac mass and performance
Grant 7,939,499 - Simons , et al. May 10, 2
2011-05-10
Method for Increasing Cardiac Mass and Performance
App 20100256063 - Simons; Michael ;   et al.
2010-10-07
Methods for Determining Collateral Artery Development in Coronary Artery Disease
App 20100092958 - Simons; Michael ;   et al.
2010-04-15
Method for detecting cardiac collateral formation
App 20090176249 - Yeo; Kiang-Tech Jerry ;   et al.
2009-07-09
Mutant proline-and-arginine rich peptides and methods for using the same
App 20090068736 - Veeraraghavan; Sudha ;   et al.
2009-03-12
Method for PR-39 peptide regulated stimulation of angiogenesis
Grant 7,345,021 - Simons , et al. March 18, 2
2008-03-18
Method for PR-39 peptide mediated selective inhibition of l.kappa.B.alpha. degradation
Grant 7,202,212 - Simons , et al. April 10, 2
2007-04-10
Method for PR-39 peptide regulated stimulation of angiogenesis
Grant 7,202,217 - Simons , et al. April 10, 2
2007-04-10
Method for PR-39 peptide mediated selective inhibition of IkappaBalpha degradation
App 20070065804 - Simons; Michael ;   et al.
2007-03-22
Method for PR-39 peptide mediated selective inhibition of I.kappa.B.alpha. degradation
Grant 7,169,604 - Simons , et al. January 30, 2
2007-01-30
Method for detecting cardiac collateral formation
App 20060084114 - Yeo; Kiang-Tech Jerry ;   et al.
2006-04-20
Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins
Grant 7,029,668 - Simons , et al. April 18, 2
2006-04-18
Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core
Grant 6,852,515 - Simons , et al. February 8, 2
2005-02-08
Stimulation of angiogenesis via syndecan-4 cytoplasmic domain signaling pathway
Grant 6,815,187 - Simons , et al. November 9, 2
2004-11-09
Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins
App 20040013653 - Simons, Michael ;   et al.
2004-01-22
Method for PR-39 peptide mediated selective inhibition of IkappaBalpha
App 20040009463 - Simons, Michael ;   et al.
2004-01-15
Peptide inhibitor of MMP activity and angiogenesis
Grant 6,667,388 - Bein , et al. December 23, 2
2003-12-23
Peptide inhibitor of MMP activity and angiogenesis
App 20020159989 - Bein, Kiflai ;   et al.
2002-10-31
Localized oligonucleotide therapy for preventing restenosis
App 20020151513 - Sirois, Martin G. ;   et al.
2002-10-17
Localized intravascular delivery of growth factors for promotion of angiogenesis
Grant 5,941,868 - Kaplan , et al. August 24, 1
1999-08-24
Localized oligonucleotide therapy
Grant 5,593,974 - Rosenberg , et al. January 14, 1
1997-01-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed